Primary Site >> Liver Cancer
Gene >> TEK
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma. PMID: 12539584 |
Ref: Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. PMID: 11915032 Ref: Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway. PMID: 12017318 |
Ref: Angiogenic switch as a molecular target of malignant tumors. PMID: 12698880 Ref: The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways. PMID: 14627514 |
Ref: [The effect of pro-angiogenic factors and their receptors on angiogenesis in hepatocellular carcinoma]. PMID: 15555336 |
Ref: Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. PMID: 16830384 Ref: [Expression of Ang2 and Tie2 and their relation with the angiogenesis of hepatocellular carcinoma in rats]. PMID: 16951510 |
Ref: Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. PMID: 22042469 |
Ref: G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency. PMID: 22699974 Ref: TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. PMID: 22815256 Ref: Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies. PMID: 24187450 Ref: The Inhibitory Effect of 3 beta -Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells through JNK and Akt Signaling Pathway. PMID: 24379889 |
Ref: Regorafenib. PMID: 24756792 Ref: Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma. PMID: 24759835 Ref: Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation. PMID: 24922356 Ref: TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. PMID: 25202690 Ref: Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma? PMID: 25202693 Ref: TIE2-expressing monocytes: a possible cellular diagnostic and prognostic biomarker for hepatocellular carcinoma. PMID: 25568866 |
Ref: Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. PMID: 25987009 Ref: Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection. PMID: 26599011 |
Ref: A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors. PMID: 26490310 Ref: Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-beta. PMID: 26584547 Ref: IFNalpha gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. PMID: 26769348 |
Ref: Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells. PMID: 28122355 Ref: RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. PMID: 28460436 Ref: TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma. PMID: 28902891 |
Ref: Regorafenib. PMID: 30069758 |